Skip to content
Home/Companies/Pharma/Kent Pharmaceuticals

Kent Pharmaceuticals

Pharma·UK·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Kent Pharmaceuticals?

Kent Pharmaceuticals is currently owned by Duke Street through DS Cornerstone Fund (2017 vintage), since 2019.

Hand-verified · updated 2026-05-29

Duke Street
Most recent investor
Duke Street
DS Cornerstone Fund · 2017 · Buyout
2 ownership periods · full history below

Key facts

HQUK
SectorPharma
StatusActive

Ownership history

1 ownership period · 1 lender on file

Active
Currently held by Duke Street since 2019.
1 holder · 1 lender · 2019 · present
Duke Street
2019 · present(7yr) · DS Cornerstone Fund · 2017 · Buyout
Apera Asset Management
2019 · present(7yr) · Apera Capital Private Debt Fund I · 2019 · Private Debt
Track Kent Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Kent Pharmaceuticals?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Kent Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue